A large British study recently revealed that cannabis capsules do not slow the progression of multiple sclerosis, offering disappointment to some who believed the drug might offer long-term benefits to patients suffering from the nerve disease.
Past Studies Offered Hope
Funded by Britain’s Medical Research Council, the research had gained the attention of MS sufferers and pharmaceutical companies who hoped to market tetrahydrocannabinol as a potential treatment for MS.
Previous smaller studies had suggested that tetrahydrocannabinol (THC), a key ingredient in cannabis, might slow the progression of MS; however, this larger, more conclusive study demonstrated that it fared no better than a placebo.
People who suffer from multiple sclerosis experience a myriad of debilitating symptoms that can make life miserable. Fortunately, many patients find very real relief when they receive oral appliance therapy.